chartexchange

Foghorn Therapeutics Reports Q3 2026 Results: Revenue Hits $83.5 Million and GAAP EPS of $1. ...

GuruFocus | Nov 9, 2026 8:31 AM EST

Collaboration revenue reaches $83.5 million, driving quarterly net income of $58.2 million Related Stocks: FHTX ,

Read original article